Market Overview

According to the investigation, the Corneal cross linking Devices market size is supposed to enroll a healthy CAGR of 13.86%. Riboflavin eye drops and a UV light source are both utilized in this method.

The collagen particles and proteoglycans interface due to the photochemical response. The rising rate and commonness of keratoconus sicknesses and the extension of the healthcare framework are anticipated to be the primary drivers of the worldwide market for CXL devices. The absence of mindfulness and treatment-related secondary effects, nonetheless, are supposed to restrict market development.

Due to the rising elderly population, the incidence of keratoconus conditions, and the concentration of key market players in the area, North America is predicted to dominate the market. The demand for CXL devices in Europe is rising because of the rise in keratoconus patients in industrialized nations.

The market is expanding in Europe because of rising keratoconus prevalence and its consequent rise, technological improvements in medicine, and rising demand for CXL devices.

Market Segmentation

Based on type, method, application, and end-user, the market for corneal cross linking devices has been segmented globally. The market is divided into accelerated cross-linking, conventional corneal cross-linking, and corneal cross-linking plus based on type.

The epithelium-off method and the epithelium-on method are two market segments based on the method. The global market for corneal cross linking devices has been divided into categories based on application, including keratoconus, pellucid marginal degeneration, refractive surgery ectasia, and others. The global market for corneal cross linking devices has been divided into hospitals, eye clinics, and ambulatory surgery centers based on end users.

Regional Analysis

Based on region, the market for corneal cross connecting devices has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World.

Due to the rising elderly population, the incidence of keratoconus conditions, and the concentration of key market players in the area, North America is predicted to dominate the market. The demand for CXL devices in Europe is rising because of the rise in keratoconus patients in industrialized nations.

The European market expansion is attributed to the growing keratoconus prevalence and its consequent rise, technological improvements in medicine, and rising demand for CXL devices. Attributable to the developing predominance of instances of eye problems is driving the market development in the Asia-Pacific area.

Organizations are going into key drives to create and market new treatment choices for patients. The remainder of the world represented the least market share in the corneal cross linking gadgets market. This is credited to less accessibility of assets and restricted clinical offices in the locale.

Key Players

The prominent players in the global Corneal Cross linking devices market include EMAGine AG (Switzerland), Glaukos Corporation (US), Peschke GmbH (Switzerland), iVIS Technologies (Italy), IROMED GROUP Srl (Italy), and AJL Ophthalmic S.A. (Spain).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING INCIDENCE AND PREVALENCE OF KERATOCONUS DISORDERS

4.2.2 IMPROVING HEALTHCARE INFRASTRUCTURE

4.3 RESTRAINTS

4.3.1 LACK OF AWARENESS REGARDING KERATOCONUS DISORDERS

4.3.2 SIDE EFFECTS ASSOCIATED WITH TREATMENT

4.4 OPPORTUNITIES

4.4.1 INCREASING PRODUCT DEVELOPMENT AND LAUNCHES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE CORNEAL CROSS-LINKING (CXL) DEVICES MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON PRODUCTION

5.3.3 IMPACT ON MARKET PLAYERS

5.4 REIMBURESEMENT SCENARIO FOR CXL PROCEDURES

6 GLOBAL RIBOFLAVIN SOLUTIONS MARKET SIZE AND STATISTICS

6.1 OVERVIEW

7 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE

7.1 OVERVIEW

7.2 STANDARD CORNEAL CROSS LINKING

7.3 CORNEAL CROSS-LINKING PLUS

7.4 ACCELERATED CROSS-LINKING

8 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD

8.1 OVERVIEW

8.2 EPITHELIUM-OFF METHOD

8.3 EPITHELIUM-ON METHOD

9 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 KERATOCONUS

9.3 PELLUCID MARGINAL DEGENERATION

9.4 REFRACTIVE SURGERY ECTASIA

9.5 OTHERS

10 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 EYE CLINICS

10.4 AMBULATORY SURGICAL CENTERS

11 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 US

11.2.2 CANADA

11.3 EUROPE

11.3.1 GERMANY

11.3.2 UK

11.3.3 FRANCE

11.3.4 ITALY

11.3.5 SPAIN

11.3.6 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 JAPAN

11.4.2 CHINA

11.4.3 INDIA

11.4.4 AUSTRALIA

11.4.5 SOUTH KOREA

11.4.6 REST OF ASIA-PACIFIC

11.5 REST OF THE WORLD

11.5.1 MIDDLE EAST

11.5.2 AFRICA

11.5.3 LATIN AMERICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW

12.2 COMPETITIVE BENCHMARKING

12.3 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET: COMPANY SHARE ANALYSIS

12.4 MAJOR GROWTH STRATEGY IN GLOBALCORNEAL CROSS-LINKING (CXL) DEVICES MARKET

12.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET

12.6 KEY DEVELOPMENT ANALYSIS

12.7 KEY DEVELOPMENTS & GROWTH STRATEGIES

12.7.1 PARTNERSHIP/COLLABORATION

12.7.2 MERGERS & ACQUISITIONS

13 COMPANY PROFILE

13.1 GLAUKOS CORPORATION

13.1.1 COMPANY OVERVIEW

13.1.2 FINANCIAL OVERVIEW

13.1.3 PRODUCTS OFFERED

13.1.4 KEY DEVELOPMENTS

13.1.5 SWOT ANALYSIS

13.1.6 KEY STRATEGIES

13.2 EMAGINE AG

13.2.1 COMPANY OVERVIEW

13.2.2 FINANCIAL OVERVIEW

13.2.3 PRODUCTS OFFERED

13.2.4 KEY DEVELOPMENTS

13.2.5 SWOT ANALYSIS

13.2.6 KEY STRATEGIES

13.3 IVIS TECHNOLOGIES

13.3.1 COMPANY OVERVIEW

13.3.2 FINANCIAL OVERVIEW

13.3.3 PRODUCTS OFFERED

13.3.4 KEY DEVELOPMENTS

13.3.5 KEY STRATEGIES

13.4 IROMED GROUP SRL

13.4.1 COMPANY OVERVIEW

13.4.2 FINANCIAL OVERVIEW

13.4.3 PRODUCTS OFFERED

13.4.4 KEY DEVELOPMENTS

13.4.5 KEY STRATEGIES

13.5 PESCHKE GMBH

13.5.1 COMPANY OVERVIEW

13.5.2 FINANCIAL OVERVIEW

13.5.3 PRODUCTS OFFERED

13.5.4 KEY DEVELOPMENTS

13.5.5 SWOT ANALYSIS

13.5.6 KEY STRATEGIES

13.6 AJL OPHTHALMIC S.A.

13.6.1 COMPANY OVERVIEW

13.6.2 FINANCIAL OVERVIEW

13.6.3 PRODUCTS OFFERED

13.6.4 KEY DEVELOPMENTS

13.6.5 KEY STRATEGIES

14 APPENDIX

14.1 REFERENCES

14.2 RELATED REPORTS

The post Corneal Cross linking Devices Market Forecast till 2030 first appeared on CRI Report.